The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer

Ovarian cancer being the first cause of death in gynecological diseases, paves the way towards increasing the search for a targeted therapy that could control the metastasis of a late-stage diagnosed ovarian cancer. HuArgI (Co)-PEG5000 is a potential drug to target cancers that depend on exogenous s...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: El Mais, Nour (author)
التنسيق: masterThesis
منشور في: 2020
الموضوعات:
الوصول للمادة أونلاين:http://hdl.handle.net/10725/13842
https://doi.org/10.26756/th.2022.368
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513468312322048
author El Mais, Nour
author_facet El Mais, Nour
author_role author
dc.creator.none.fl_str_mv El Mais, Nour
dc.date.none.fl_str_mv 2020
2020-05-22
2022-07-20T08:43:07Z
2022-07-20T08:43:07Z
dc.identifier.none.fl_str_mv http://hdl.handle.net/10725/13842
https://doi.org/10.26756/th.2022.368
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv Lebanese American University
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Ovaries -- Cancer -- Treatment
Cancer cells -- Motility
Arginine -- Therapeutic use
Lebanese American University -- Dissertations
Dissertations, Academic
dc.title.none.fl_str_mv The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer
dc.type.none.fl_str_mv Thesis
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/masterThesis
description Ovarian cancer being the first cause of death in gynecological diseases, paves the way towards increasing the search for a targeted therapy that could control the metastasis of a late-stage diagnosed ovarian cancer. HuArgI (Co)-PEG5000 is a potential drug to target cancers that depend on exogenous sources of arginine and cannot synthesize their own. In this study, we hypothesized that HuArgI (Co)- PEG5000 can decrease the migration of ovarian cancer cells. Our results show a decrease in the migratory rate of the cells and their rate in wound closure. The second thing we looked into was the adhesion of those cells and the formation of focal adhesions. The number and area of focal adhesions were quantified and the results show a decrease in the area and number of focal adhesions upon treating with HuArgI (Co)-PEG5000. Finally, we looked at the effect of HuArgI (Co)-PEG5000 on 3D motility of the ovarian cancer cell line, using a collagen based assay. It showed that SKOV3 cell line does not show significant invasiveness to collagen. In conclusion, we noticed an effect on ovarian cancer by treating the cells with HuArgI (Co)-PEG5000 which opens the way for further studies on the effect of arginine deprivation and autophagy induction on the migration of ovarian cancer.
eu_rights_str_mv openAccess
format masterThesis
id LAURepo_234fd8787d0fc7fd0201762c846deb61
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/13842
publishDate 2020
publisher.none.fl_str_mv Lebanese American University
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian CancerEl Mais, NourOvaries -- Cancer -- TreatmentCancer cells -- MotilityArginine -- Therapeutic useLebanese American University -- DissertationsDissertations, AcademicOvarian cancer being the first cause of death in gynecological diseases, paves the way towards increasing the search for a targeted therapy that could control the metastasis of a late-stage diagnosed ovarian cancer. HuArgI (Co)-PEG5000 is a potential drug to target cancers that depend on exogenous sources of arginine and cannot synthesize their own. In this study, we hypothesized that HuArgI (Co)- PEG5000 can decrease the migration of ovarian cancer cells. Our results show a decrease in the migratory rate of the cells and their rate in wound closure. The second thing we looked into was the adhesion of those cells and the formation of focal adhesions. The number and area of focal adhesions were quantified and the results show a decrease in the area and number of focal adhesions upon treating with HuArgI (Co)-PEG5000. Finally, we looked at the effect of HuArgI (Co)-PEG5000 on 3D motility of the ovarian cancer cell line, using a collagen based assay. It showed that SKOV3 cell line does not show significant invasiveness to collagen. In conclusion, we noticed an effect on ovarian cancer by treating the cells with HuArgI (Co)-PEG5000 which opens the way for further studies on the effect of arginine deprivation and autophagy induction on the migration of ovarian cancer.1 online resource (xi, 60 leaves): col. ill.Bibliography: leaf 48-50.Lebanese American University2022-07-20T08:43:07Z2022-07-20T08:43:07Z20202020-05-22Thesisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesishttp://hdl.handle.net/10725/13842https://doi.org/10.26756/th.2022.368http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.phpeninfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/138422022-07-20T08:47:15Z
spellingShingle The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer
El Mais, Nour
Ovaries -- Cancer -- Treatment
Cancer cells -- Motility
Arginine -- Therapeutic use
Lebanese American University -- Dissertations
Dissertations, Academic
status_str publishedVersion
title The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer
title_full The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer
title_fullStr The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer
title_full_unstemmed The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer
title_short The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer
title_sort The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer
topic Ovaries -- Cancer -- Treatment
Cancer cells -- Motility
Arginine -- Therapeutic use
Lebanese American University -- Dissertations
Dissertations, Academic
url http://hdl.handle.net/10725/13842
https://doi.org/10.26756/th.2022.368
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php